[1] Alzheimer's Association. 2015 Alzheimer's disease facts
and figures[R].
Alzhmer's & Dementia, 2015, 11(3): 332-384.
[2] Rebecca Nisbet, Juan Carlos Polanco, Lars
Matthias Ittner, et al. Tau aggregation and its interplay
with amyloid-β[J].
Acta Neuropathol, 2015, 129(2): 207-220.
[3] Terry R D, Masliah E, Salmon D P, et al. Physical basis of cognitive
alterations in Alzheimer's disease: synapse loss is the major correlate of
cognitive impairment[J].
Annals of Neurology, 1991, 30(4): 572-580.
[4] Li Chuan-yu, Zhao Rui, Gao Kai, et al. Astrocytes: implications for
neuroinflammatory pathogenesis of Alzheimer's disease[J]. Current Alzheimer
Research, 2011, 8(1): 67-80.
[5] Zsuzsanna Nagy. The last neuronal division: a
unifying hypothesis for the pathogenesis of Alzheimer's disease[J]. J Cellular and
Molecular Medicine, 2005, 9(3): 531-541.
[6] Kenneth Beagley, Wilhelmina M Huston, Philip
Hansbro, et al. Chlamydial infection of immune
cells: altered function and implications for disease[J]. Critical Reviews
in Immunology, 2009, 29(4): 275-305.
[7] Charles W Stratton, Subramaniam Sriram. Association of Chlamydia
pneumoniae with central nervous system disease[J]. Microbes and Infection,
2003, 5(13): 1249-1253.
[8] Katerina Wolf, Elizabeth Fischer, Ted
Hackstadt. Ultrastructural analysis of
developmental events in Chlamydia pneumoniae-infected cells[J]. Infection and Immunity,
2000, 68(4): 2379-2385.
[9] Brian J Balin, Herve C Gérard, E James
Arking, et al. Identification and localization
of Chlamydia pneumoniae in the Alzheimer's brain[J]. Medical Microbiology
and Immunology, 1998, 187(1): 23-42.
[10] Herve C Gérard, Ute Dreses-Werringloer, Kristin
S Wildt, et al. Chlamydophila (Chlamydia)
pneumoniae in the Alzheimer's brain[J]. FEMS immunology and medical
microbiology, 2006, 48(3): 355-366.
[11] Christine J Hammond, Loretta R Hallock, Raymond
J Howanski, et al. Immunohistological detection of
Chlamydia pneumoniae in the Alzheimer's disease brain[J]. BMC Neuroscience,
2010, 11(1): 121.
[12] Itzhaki R F, Wozniak M A, Appelt D M, et al. Infiltration of the brain by
pathogens causes Alzheimer's disease[J]. Neurobiology of Aging, 2004,
25(5): 619-627.
[13] Judith Miklossy. Historic evidence to support a
causal relationship between spirochetal infections and Alzheimer's disease[J]. Frontiers in
Aging Neuroscience, 2015, 7: 46.
[14] Garth Nicolson. Chronic bacterial and viral
infections in neurodegenerative and neurobehavioral diseases[J]. Laboratory
Medicine, 2008, 39(5): 291-299.
[15] Ingar Olsen, Sim Singhrao. Can oral infection be a risk
factor for Alzheimer's disease?[J]. J Oral Microbiology, 2015,
7(1): 29143.
[16] Judith Miklossy, Sandor Kasas, Robert C Janzer, et al. Further ultrastructural evidence
that spirochaetes may play a role in the aetiology of Alzheimer's disease[J]. Neuroreport, 1994,
5(10): 1201-1204.
[17] Judith Miklossy. Bacterial amyloid and DNA are important
constituents of senile plaques: further evidence of the spirochetal and biofilm
nature of senile plaques[J]. J Alzheimer's Disease: JAD, 2016, 53(4):
1459-1473.
[18] Judith Miklossy, Kamel Khalili, Lise Gern, et al. Borrelia burgdorferi persists in
the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer
disease[J].
Journal of Alzheimer's disease: JAD, 2004, 6(6): 639-649.
[19] Miklossy J, Kis A, Radenovic A, et al. Beta-amyloid deposition and
Alzheimer's type changes induced by Borrelia spirochetes[J]. Neurobiology of Aging,
2006, 27(2): 228-236.
[20] Riviere G R, Riviere K H, Smith K S. Molecular and immunological
evidence of oral Treponema in the human brain and their association with
Alzheimer's disease[J].
Oral Microbiology and Immunology, 2002, 17(2): 113-118.
[21] Judith Miklossy. Alzheimer's disease - a
neurospirochetosis. Analysis of the evidence following Koch's and Hill's
criteria[J].
Journal of Neuroinflammation, 2011, 8(1): 90.
[22] BarryJ Marshall, J Robin Warren. Unidentified curved bacilli in
the stomach of patients with gastritis and peptic ulceration[J]. Lancet (London,
England), 1984, 1(8390): 1311-1315.
[23] Dulciene M M Queiroz, Andreia M C Rocha, Jean
E Crabtree. Unintended consequences of
Helicobacter pylori infection in children in developing countries: iron
deficiency, diarrhea, and growth retardation[J]. Gut Microbes, 2013, 4(6):
494-504.
[24] Claire Roubaud Baudron, Christine Varon, Francis
Mégraud, et al. Alzheimer's disease and
Helicobacter pylori infection:a possible link?][J]. Geriatrie et Psychologie
Neuropsychiatrie du Vieillissement, 2016, 14(1): 86-94.
[25] May A Beydoun, Hind A Beydoun, Martine
Elbejjani, et al. Helicobacter pylori
seropositivity and its association with incident all-cause and Alzheimer's
disease dementia in large national surveys[J]. Alzheimer's & Dementia :
J Alzheimer's Association, 2018, 14(9): 1148-1158.
[26] Jannis Kountouras, Marina Boziki, Emmanuel Gavalas
E, et al. Eradication of Helicobacter
pylori may be beneficial in the management of Alzheimer's disease[J]. J Neurology, 2009,
256(5): 758-767.
[27] Chang Yang-pei, Chiu Guei-Fen, Kuo Fu-Chen, et al. Eradication of helicobacter
pylori is associated with the progression of dementia: A population-based study[J]. Gastroenterology Research
and Practice, 2013, (16): 175729.
[28] Seiji Shiota, Kazunari Murakami, Aoi Yoshiiwa, et al. The relationship between
Helicobacter pylori infection and Alzheimer's disease in Japan[J]. J Neurology, 2011,
258(8): 1460-1463.
[29] Guo Yong-hua, Ky-Anh Nguyen, Jan Potempa. Dichotomy of gingipains action as
virulence factors: from cleaving substrates with the precision of a surgeon's
knife to a meat chopper-like brutal degradation of proteins[J]. Periodontology,
2000, 2010, 54(1): 15-44.
[30] Sim Singhrao, Alice Harding, Sophie Poole, et al. Porphyromonas gingivalis periodontal
infection and its putative links with Alzheimer's disease[J]. Mediators of Inflammation,
2015, (4): 137357.
[31] Stephen S Dominy, Casey Lynch, Florian Ermini, et al. Porphyromonas gingivalis in
Alzheimer's disease brains: Evidence for disease causation and treatment with
small-molecule inhibitors[J]. Science Advances, 2019, 5(1): eaau3333.
[32] Vladimir Ilievski, Paulina K Zuchowska, Stefan
J Green, et al. Chronic oral application of a
periodontal pathogen results in brain inflammation, neurodegeneration and
amyloid beta production in wild type mice[J]. PloS One, 2018, 13(10):
e0204941.
[33] Ding Ye, Ren Jing-yi, Yu Hong-qiang, et al. Porphyromonas gingivalis, a
periodontitis causing bacterium, induces memory impairment and age-dependent
neuroinflammation in mice[J]. Immunity & Ageing : I & A, 2018, 15(1):
6.
[34] Nie Ran, Wu Zhou, Ni Jun-jun, et al. Porphyromonas gingivalis
infection induces amyloid-β accumulation in monocytes/macrophages[J]. J Alzheimer's Disease:
JAD, 2019, 72(2): 479-494.
[35] Diana Pisa, Ruth Alonso, Alberto Rábano, et al. Different brain regions are
infected with fungi in Alzheimer's disease[J]. Scientific Reports, 2015, 5:
15015.
[36] Ruth Alonso, Diana Pisa, Alberto Rábano, et al. Alzheimer's disease and
disseminated mycoses[J].
European J Clinical Microbiology & Infectious Diseases: Official
Publication of the European Society of Clinical Microbiology, 2014, 33(7):
1125-1132.
[37] Ruth Alonso, Diana Pisa, Anabel Marina, et al. Fungal infection in patients with
Alzheimer's disease[J].
J Alzheimer's Disease: JAD, 2014, 41(1): 301-311.
[38] Ruth Alonso, Diana Pisa, Ana M Fernández-Fernández, et al. Infection of fungi and bacteria
in brain tissue from elderly persons and patients with Alzheimer's disease[J]. Frontiers in Aging
Neuroscience, 2018, 10: 159.
[39] Diana Pisa, Ruth Alonso, Alberto Rábano A, et al. Fungal Enolase, β-Tubulin, and chitin
are detected in brain tissue from Alzheimer's disease patients[J]. Frontiers in Microbiology,
2016, 7(179): 1772.
[40] Ann-Marie Lobo, Alex Agelidis, Deepak Shukla. Pathogenesis of herpes simplex
keratitis: The host cell response and ocular surface sequelae to infection and
inflammation[J].
The Ocular Surface, 2019, 17(1): 40-49.
[41] Steven A Harris, Elizabeth Harris. Herpes simplex virus type 1 and
other pathogens are key causative factors in sporadic Alzheimer's disease[J]. J Alzheimer's Disease:
JAD, 2015, 48(2): 319-353.
[42] Federico Licastro, IIaria Carbone, Elena
Raschi, et al. The 21st century epidemic:
infections as inductors of neuro-degeneration associated with Alzheimer's
Disease[J].
Immunity & Ageing: I & A, 2014, 11(1): 22.
[43] 孙奕, 周辰, 潘晓东, 等. 1型单纯疱疹病毒抗体与阿尔茨海默病的关联研究[J]. 徐州医科大学学报, 2017, 37(6): 372-376.
[44] Ruth F Itzhaki, Richard Lathe, Brian J Balin, et al. Microbes and Alzheimer's disease[J]. J Alzheimer's
Disease: JAD, 2016, 51(4): 979-984.
[45] Ruth F Itzhaki. Corroboration
of a major role for herpes simplex virus type 1 in Alzheimer's disease[J]. Frontiers in Aging
Neuroscience, 2018, 10: 324.
[46] Hugo Lovheim, Jonathan Gilthorpe, Rolf
Adolfsson, et al. Reactivated herpes simplex
infection increases the risk of Alzheimer's disease[J]. Alzheimer's &
Dementia: J Alzheimer's Association, 2015, 11(6): 593-599.
[47] Nell S Lurain, Barbara Hanson, Jeffrey Martinson, et al. Virological and immunological
characteristics of human cytomegalovirus infection associated with Alzheimer
disease[J].
The J Infectious Diseases, 2013, 208(4): 564-572.
[48] Stefania Varani, Maria Paola Landini. Cytomegalovirus-induced
immunopathology and its clinical consequences[J]. Herpesviridae,
2011, 2(1): 6.
[49] Ilaria Carbone, Tiziana Lazzarotto, Manuela
Ianni, et al. Herpes virus in Alzheimer's
disease: relation to progression of the disease[J]. Neurobiology of Aging,
2014, 35(1): 122-129.
[50] Lisa Barnes, Ana W Capuano, Alison E Aiello, et al. Cytomegalovirus infection and
risk of Alzheimer disease in older black and white individuals[J]. The J Infectious
Diseases, 2015, 211(2): 230-237.
|